MiNK Therapeutics, Inc.
NASDAQ:INKT
0.729 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 3.367 | 19.636 | 38.889 | 2.691 | 0.299 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 3.367 | 19.636 | 38.889 | 2.691 | 0.299 |
| Net Receivables
| 0 | 0 | 0.023 | 0.02 | 0.317 |
| Inventory
| 0 | 0 | 0.002 | 1.031 | 0.088 |
| Other Current Assets
| 0.231 | 0.47 | 0.721 | 0.355 | 0.215 |
| Total Current Assets
| 3.598 | 20.405 | 39.635 | 4.097 | 0.918 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 0.954 | 1.067 | 0.607 | 0.458 | 0.391 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| -0 | -0 | 0 | 0 | -0 |
| Total Non-Current Assets
| 0.954 | 1.067 | 0.607 | 0.458 | 0.391 |
| Total Assets
| 4.552 | 21.472 | 40.242 | 4.555 | 1.309 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 3.912 | 5.823 | 2.996 | 3.142 | 2.456 |
| Short Term Debt
| 0 | 0 | 0 | 0 | 4.758 |
| Tax Payables
| 0 | 0 | 0 | 0.324 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0.191 |
| Other Current Liabilities
| 7.491 | 6.86 | 13.469 | 11.08 | 0.014 |
| Total Current Liabilities
| 11.403 | 12.683 | 16.465 | 14.222 | 7.419 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 0 | 0 | 0 | 43.824 | 26.79 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 11.205 | 9.19 | 0 | 0.383 | 3.433 |
| Total Non-Current Liabilities
| 11.205 | 9.19 | 0 | 44.207 | 30.224 |
| Total Liabilities
| 22.608 | 21.873 | 16.465 | 58.429 | 37.643 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0 | 0 | 0 | 0 | 0 |
| Retained Earnings
| -133.397 | -110.939 | -82.948 | -52.735 | -36.496 |
| Accumulated Other Comprehensive Income/Loss
| -0.431 | -0.292 | -0.625 | -1.523 | -0.133 |
| Other Total Stockholders Equity
| 115.772 | 110.83 | 107.349 | 0.384 | 0.295 |
| Total Shareholders Equity
| -18.055 | -0.401 | 23.776 | -53.874 | -36.334 |
| Total Equity
| -18.055 | -0.401 | 23.776 | -53.874 | -36.334 |
| Total Liabilities & Shareholders Equity
| 4.552 | 21.472 | 40.242 | 4.555 | 1.309 |